Toripalimab With Preoperative Chemoradiotherapy for LA-EGJ

Clinical trial NCT04061928 · UNKNOWN

Trial details

NCT number: NCT04061928
Sponsor: Peking University
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

PD-1 Chemoradiotherapy Gastroesophageal Junction Cancer

Start date: 2019-08-26
Primary completion: 2022-08-25
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.